Peter Loftus writes about the pharmaceutical industry and health care for the Wall Street Journal from Philadelphia. His coverage areas include large drugmakers such as Johnson & Johnson, Merck, and Eli Lilly and the latest developments in drug research.
~~tag-text~~
The story of the biotech unicorn in the right place, at the right time, with the right technology. At the start of 2020, Moderna was a waning biotech unicorn, still years away from delivering its first product despite a decade of development of a pote... SEE MORE